Jh. Prystowsky et al., EFFECT OF UVB PHOTOTHERAPY AND ORAL CALCITRIOL (1,25-DIHYDROXYVITAMIN-D-3) ON VITAMIN-D PHOTOSYNTHESIS IN PATIENTS WITH PSORIASIS, Journal of the American Academy of Dermatology, 35(5), 1996, pp. 690-695
Background: Phototherapy and activated forms of vitamin D help clear p
soriasis. Objective: The influence of UVB phototherapy and oral calcit
riol (1,25-dihydroxyvitamin D-3) On vitamin D photosynthesis was asses
sed in 16 patients. Methods: Patients were randomly selected to receiv
e orally either placebo or calcitriol (0.5 to 2 mu g daily) for the du
ration of the 8-week study; all patients received approximately 21 UVB
treatments. Before and after treatment, serum levels of 25-hydroxyvit
amin D and calcitriol were measured by high-pressure liquid chromatogr
aphy. Results: Although calcitriol had no additive effect on photother
apy as a treatment modality, a significant increase in serum 25-hydrox
yvitamin D levels occurred in both groups; in three patients extraordi
narily high levels developed (>120 ng/ml). Oral calcitriol significant
ly increased calcitriol serum levels. Increased serum calcitriol did n
ot inhibit cutaneous synthesis of vitamin D or its hepatic conversion
to serum 25-hydroxyvitamin D. Conclusion: UVB induces high levels of v
itamin D photosynthesis. Because oral or topical calcitriol alone help
s clear psoriasis, studies to explore the possible influence of UVB ph
ototherapy on its production should be considered. If UVB phototherapy
induces cutaneous calcitriol synthesis this could explain the lack of
added benefit to treatment when oral calcitriol is administered with
phototherapy.